Robert H. Christman

Bob and I met at a Lymphoma Research Foundation MCL workshop shortly after his dx and joining the MSK trial. We then had email contact through the ACOR MCL online group of 400 MCL folks worldwide, and the occasional phone call. I admired his sense of humor and optimism in trying to manage treatment issues and concerns. His questions were challenging yet spot on, reflecting his hope for a durable remission. I am saddened to hear that his wish was not granted. My deepest sympathies to his family.